The ADDF is proud to be an official charity partner for the 2017 TCS New York City Marathon. Donations to our team, Runners for Alzheimer's Research, directly support research into new treatments for this devastating disease. In 2016, our eighteen team members raised over $100,000, far surpassing their goal.
Though we are making great strides, Alzheimer's remains the only top 10 cause of death in the U.S. that can't be prevented, cured or even slowed. By supporting drug discovery research, our marathon team will help conquer Alzheimer's!
If you are interested in running for our team, please visit our team page.
Founded in 1998 by co-chairmen Leonard A. and Ronald S. Lauder, the ADDF provides funding to leading scientists who are conducting the most promising, innovative Alzheimer’s drug research worldwide. The mission of the ADDF is to rapidly accelerate the discovery of drugs to prevent, treat and cure Alzheimer's disease.
To learn more about the ADDF, please visit our website.